Work

Abstract P5-03-07: Molecular characterization of CDK 4/6 inhibitors (palbociclib, abemaciclib, and ribociclib) in hormone receptor-positive (HR+) breast cancer cell lines

Year: 2016

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs15-p5-03-07

Authors: K Petrossian, C Lo, Y Yuan, N Kanaya, SV Wu, T Synold, C-S Huang, S Chen

Institutions: City Of Hope National Medical Center, City of Hope, National Taiwan University Hospital, Beckman Research Institute

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2399480446

Cites:

Cited by:

Related to: 10